Great news for CEO Teresa Prego & jairo tavera's EpiWatch Johns Hopkins Epilepsy Center winning Baltimore Business Journal's INNO Fire Award! Created for the Apple Watch to detect epileptic seizures, the app already has a waiting list! bit.ly/3S30tSL

Great to see Brené Brown 's interview with Lauren Choi, Pava Marie LaPere Center for Entrepreneurship and Johns Hopkins Engineering alum and founder of The New Norm, a company reshaping the future of plastics! bit.ly/3zMthJ4

Using genetic engineering techniques, a team of investigators, including JHTV, from Sidney Kimmel Comprehensive Cancer Center and its Ludwig Center, the Lustgarten Laboratory & Bloomberg~Kimmel Institute , have designed a novel cell type to recognize and fight cancer. bit.ly/3y22198 #innovation

Unique among universities, Johns Hopkins University' research development team stands out by assisting faculty in securing large-scale grants through their tailored proposal development support & thoughtful fostering of collaboration across disciplines. bit.ly/4cO4HWV Denis Wirtz

New gene-editing approach offers hope to sickle cell patients! Xizhen Lian researcher with Johns Hopkins Engineering The Institute for NanoBioTechnology (INBT) Johns Hopkins Medicine, says "This gene editing approach would allow patients to receive the medicine through a transfusion." bit.ly/4c3FeHJ

Great news from our JHTV principal investigators!

Our July Newsletter is out! Check out our new video interview and Q&A with faculty investigators, along with exciting updates from our startup community and broader ecosystem! bit.ly/3AeF17f Kubanda Cryotherapy Leonardo DRS Rapafusyn Pharmaceuticals

Our Maryland-Virginia-Washington DC Biohealth Capital Region has been ranked third in the nation, following San Francisco and Boston, among the top 10 Biopharma Clusters!bit.ly/3AcCVoM Johns Hopkins Engineering Johns Hopkins University @KimmelCancer The Institute for NanoBioTechnology (INBT)

Groundbreaking new drug for the treatment of a lethal type of brain cancer, called low-grade glioma, was approved on August 6th by the U.S. FDA. Vorasidenib, discovered by Johns Hopkins Kimmel Cancer Center, is the first ever hope for the treatment of glioma. Servier Pharmaceuticals bit.ly/46C1ur6

Great to see one of Johns Hopkins APL's & JHTV companies Oculi listed as one of EE Times | Electronic Engineering Times 100 startups to watch! bit.ly/4fBZ3Jk

Join Anchor Ventures on Sept 12 for Resources to Build Your Life Sciences Company in the Baltimore Region! Discover new resources & initiatives including Connect Labs Baltimore. UM Ventures, College Park shorturl.at/NyWS1

Read about new findings published in the American Journal of Gastroenterology related to Esopredict, a commercially available test for esopageal cancer developed at Johns Hopkins and manufactured by Previse, one of our Baltimore startups! ventures.jhu.edu/news/novel-tes…

ICYMI in our July newsletter, we interviewed Sashank Reddy JHTV's Medical Director & Assoc. Director of The Institute for NanoBioTechnology (INBT) He's also the founder & president of LifeSprout Watch Reddy's video here ventures.jhu.edu/news/innovator…

Johns Hopkins was awarded $21M from ARPA-H to develop groundbreaking technology for removing cancerous tumors with unprecedented precision. We are extremely honored as this marks the first ARPA-H award where JHU is the lead institution and prime recipient shorturl.at/S8J2x

A phase II clinical trial led by Johns Hopkins Kimmel Cancer Center reveals that the anti-cancer drug olaparib may treat biochemically recurrent prostate cancer in men with BRCA2 mutations w/o hormone therapy Cathy Handy Marshall, MD MPH & Emmanuel Antonarakis led the study published in JAMA Oncology shorturl.at/inMI8

Announcing JHTV’s FY24 annual report! This year marks a decade of supporting our incredible faculty & students. We invite you to celebrate our progress, successes & the innovators. Huge thanks to our supporters as we look forward to FY25 & beyond! tinyurl.com/3dhrvy8j

Our new Communications Associate will play a crucial role in enhancing JHU's reputation as a leader in innovation & entrepreneurship. If you’re ready to make an impact & be part of a vibrant community, apply today! tinyurl.com/4sn5a6e4

Join Anchor Ventures on Sept. 12 to explore new tech resources in Baltimore! Hear from experts and tour Connect Labs Baltimore at 4MLK. Tours start at 4 p.m. from 801 W. Baltimore St. Closed-toe shoes required. tinyurl.com/2mr55vbz

New Breakthrough in Breast Cancer Research! Johns Hopkins Kimmel Cancer Center researchers have identified a potential immune system target to stop the spread of breast cancer cells. Could this lead to new immunotherapies? Read more in Oncogene. tinyurl.com/bdh63sr5

Fourth in our video series of celebrating 10 years of innovation & faculty contributions is Netz Arroyo-Curras, Ph.D. whose research on implantable biosensors will revolutionize future drug development . Watch here tinyurl.com/57rbuk2h